Beta-lactam antibiotics

Beta-lactam antibiotics exert their bactericidal effect by inhibiting the final step of peptidoglycan cross-linking in bacterial cell walls. They bind covalently to penicillin-binding proteins (PBPs), which are transpeptidases essential for cell wall integrity, thereby disrupting the cell wall and causing osmotic lysis.¹ This mechanism is selective for bacteria because mammalian cells lack peptidoglycan cell walls.

The beta-lactam class includes several subclasses with varying spectra and resistance profiles. Penicillins (e.g., penicillin G, amoxicillin) are effective against many Gram-positive bacteria. Cephalosporins are grouped into generations with expanded Gram-negative coverage. Carbapenems (e.g., imipenem) are broad-spectrum and resistant to many beta-lactamases. Monobactams (e.g., aztreonam) target Gram-negative bacteria only. Beta-lactamase inhibitors (e.g., clavulanic acid) are often combined with penicillins to overcome resistance.²

Bacterial resistance to beta-lactams arises primarily through three mechanisms: production of beta-lactamase enzymes that hydrolyze the ring, modification of PBPs reducing drug affinity, and changes in outer membrane permeability or efflux pumps. The spread of extended-spectrum beta-lactamases (ESBLs) and carbapenemases (e.g., KPC, NDM) poses a major clinical challenge.³

Beta-lactams are used to treat a wide range of infections, including pneumonia, sepsis, meningitis, and skin infections. They are generally well-tolerated, but hypersensitivity reactions are the most common adverse effect, ranging from mild rashes to anaphylaxis. Cross-reactivity between penicillins and cephalosporins is lower than historically believed.⁴

Beyond the well-known subclasses, several lesser-known facets exist. The first beta-lactamase, penicillinase, was identified in 1940 in E. coli before penicillin was widely used. Clavulanic acid, the first beta-lactamase inhibitor, was isolated from Streptomyces clavuligerus in 1976. Monobactams are unusual because they are resistant to metallo-beta-lactamases. Also, some beta-lactams like ceftobiprole and ceftaroline are called 'fifth-generation' cephalosporins with anti-MRSA activity. The 'beta-lactam' ring is also found in some non-antibiotic drugs, such as the cholesterol-lowering agent ezetimibe, which inhibits sterol absorption.⁵

Beta-lactam ring

A four-membered cyclic amide ring that is the core structure of beta-lactam antibiotics.

Penicillin-binding proteins (PBPs)

Enzymes involved in bacterial cell wall synthesis that are the targets of beta-lactam antibiotics.

Beta-lactamase

An enzyme produced by bacteria that hydrolyzes the beta-lactam ring, conferring resistance.

Carbapenem

A subclass of beta-lactam antibiotics with an exceptionally broad spectrum and resistance to many beta-lactamases.

Monobactam

A beta-lactam antibiotic with a monocyclic ring, active only against Gram-negative bacteria.